Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves’ disease. A reliable indicator for remission and persistence of this disease?
- 11 April 1978
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 1 (2), 155-161
- https://doi.org/10.1007/bf03350364
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Short-Term Antithyroid Drug Therapy for the Thyrotoxicosis of Graves's DiseaseNew England Journal of Medicine, 1977
- VALUE OF THYROID-STIMULATING-ANTIBODY DETERMINATIONS IN PREDICTING SHORT-TERM THYROTOXIC RELAPSE IN GRAVES' DISEASEThe Lancet, 1977
- Identification of Subgroups of Euthyroid Graves's OphthalmopathyNew England Journal of Medicine, 1977
- RELATION OF THYROID-STIMULATING IMMUNOGLOBULINS TO THYROID FUNCTION AND EFFECTS OF SURGERY, RADIOIODINE, AND ANTITHYROID DRUGSThe Lancet, 1975
- TRH stimulation test with age and sex specific TSH response in normal subjectsKlinische Wochenschrift, 1974
- QUANTITATIVE THYROID SCANNING: A RELIABLE THYROID FUNCTION TESTAmerican Journal of Roentgenology, 1974
- THE PATHOGENESIS OF GRAVES' DISEASE AND HASHIMOTO'S THYROIDITISClinical Endocrinology, 1974
- Binding of thyroid stimulators to thyroid membranesFEBS Letters, 1974
- Correlation between Long-acting Thyroid Stimulator Protector Level and Thyroid 131I Uptake in ThyrotoxicosisBMJ, 1974
- SEQUENTIAL ASSESSMENT DURING DRUG TREATMENT OF THYROTOXICOSISClinical Endocrinology, 1973